Global Viral Gastroenteritis Market, By Type (Norovirus, Rotavirus), Treatment (Intravenous Fluids, Antimotility Agents, Electrolytes, Antiemetic Drugs, Antidiarrheal Drugs, Others), Diagnosis (Physical Examination, Rapid Stool Test, Others), Indication (Abdominal Pain, Dizziness, Diarrhea, Nausea, Vomiting, Headache, Chills, Loss of Appetite, Fever, Joint Stiffness, Sweating, Muscle Pain, Weight Loss, Others), Dosage (Tablet, Injection, Others), Route of Administration (Oral, Intravenous, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights: Global Viral Gastroenteritis Market
Viral gastroenteritis market is expected to gain market growth in the forecast period of 2021-2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 3.99% in the above mentioned forecast period.
The interior lining of your gastrointestinal tract is inflamed, swollen, and irritated by viral gastroenteritis. This sickness is caused by a virus. Your stomach, small intestine, and large intestine can all be infected. Viral gastroenteritis is very common. It usually only lasts a few days and does not necessitate therapy. The most serious risk is dehydration as a result of fluid loss through vomiting and diarrhea. It's also known as stomach flu. This condition is characterized by abdominal pain, dizziness, diarrhea, nausea, vomiting, headache, chills, loss of appetite, fever, joint stiffness, sweating, muscle pain, weight loss, among others.
The rise in the prevalence of gastrointestinal diseases and rising healthcare expenditure are the major factors influencing the market growth rate. Furthermore, growing geriatric population, new product launches and rising initiatives by public and private organisations to spread awareness about the disease and its preventive options are the factors that will expand the viral gastroenteritis market. Similarly, other factors such as increasing urbanization and growing awareness towards health will positively impact the market growth rate.
Rise in the research and development activities, increase in the number of pipeline products and clinical trials on rare disorders will provide beneficial opportunities for the viral gastroenteritis market in the forecast period of 2021-2028.
However, high cost of the treatment, complications associated with the disease such as severe dehydration and high initial investment needed in research and development activities for the enhancement of vaccines, drugs and kits utilized in the treatment are the factors that will hinder the market growth. Lack of awareness and strict regulations imposed on the treatment and usage of chemicals in drug manufacturing procedure will further challenge the viral gastroenteritis market in the forecast period mentioned above.
This viral gastroenteritis market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the viral gastroenteritis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Viral Gastroenteritis Market Scope and Market Size
The viral gastroenteritis market is segmented on the basis of type, treatment, diagnosis, indication, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, the viral gastroenteritis market is segmented into norovirus and rotavirus.
- On the basis of treatment, the viral gastroenteritis market is segmented into intravenous fluids, antimotility agents, electrolytes, antiemetic drugs, antidiarrheal drugs and others.
- On the basis of diagnosis, the viral gastroenteritis market is segmented into physical examination, rapid stool test and others.
- On the basis of indication, the viral gastroenteritis market is segmented into abdominal pain, dizziness, diarrhea, nausea, vomiting, headache, chills, loss of appetite, fever, joint stiffness, sweating, muscle pain, weight loss and others.
- On the basis of dosage, the viral gastroenteritis market is segmented into tablet, injection and others.
- On the basis of route of administration, the viral gastroenteritis market is segmented into oral, intravenous and others.
- On the basis of end-users, the viral gastroenteritis market is segmented into clinic, hospital and others.
The viral gastroenteritis market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Viral Gastroenteritis Market Country Level Analysis
Viral gastroenteritis market is analyzed and market size information is provided by the country, type, treatment, diagnosis, indication, dosage, route of administration, end-users and distribution channel as referenced above.
The countries covered in the viral gastroenteritis market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the viral gastroenteritis market due to the rising awareness about diseases, health related problems arising due to presence of major key players, rise in the prevalence of viral gastroenteritis and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, rising demand for rapid diagnostic tests gastrointestinal diseases and growing awareness about available treatment option for viral gastroenteritis.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Viral gastroenteritis market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Viral Gastroenteritis Market Share Analysis
Viral gastroenteritis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to viral gastroenteritis market research.
The major players covered in the viral gastroenteritis market report are Pfizer Inc., GlaxoSmithKline plc, Sanofi, Novartis AG, Sun Pharmaceutical Industries Ltd., Johnson & Johnson Private Limited, Allergan, Bayer AG, Baxter, AstraZeneca, Bausch Health Companies Inc., Takeda Pharmaceutical Company Limited., Mylan N.V., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma, Lupin, Fresenius Kabi AG, Amneal Pharmaceuticals LLC, Zydus Cadila, Merck Sharp & Dohme Corp., Eli Lilly and Company, Bristol-Myers Squibb Company, Cipla Inc., Astellas Pharma Inc., Abbott, Dr. Reddy’s Laboratories Ltd., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-